Insmed, Inc. (INSM) - NASDAQ
From other sites
Company Description
Insmed, Inc. operates as a biopharmaceutical company focused on developing and commercializing inhaled therapies for patients battling serious lung diseases that are often life threatening. The company is focused on the development and commercialization of ARIKAYCE or liposomal amikacin for... More
Sector: Healthcare
Industry: Biotechnology
Country: United States